These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Special issues in the management of patients with ESRD and HIV infection. Ahuja TS; O'brien WA Am J Kidney Dis; 2003 Feb; 41(2):279-91. PubMed ID: 12552489 [TBL] [Abstract][Full Text] [Related]
26. Composition of polymer membranes for therapies of end-stage renal disease. Radovich JM Contrib Nephrol; 1995; 113():11-24. PubMed ID: 7712717 [No Abstract] [Full Text] [Related]
27. [History, present status and perspectives of the development of renal replacement therapy in South-Eastern of Poland]. Sulowicz W; Krzanowki M; Walatek B Przegl Lek; 2001; 58 Suppl 6():26-9. PubMed ID: 11873738 [No Abstract] [Full Text] [Related]
28. Development of continuous implantable renal replacement: past and future. Fissell WH; Fleischman AJ; Humes HD; Roy S Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594 [TBL] [Abstract][Full Text] [Related]
29. Appropriate preparation for renal replacement therapy. Origins, rationale & implications for practice improvement. Haley WE Nephrol News Issues; 2003 Mar; 17(4):14-8. PubMed ID: 12696522 [No Abstract] [Full Text] [Related]
30. Successful CAVH in an austere environment using readily available disposable hospital supplies. Perkins RM; George R; Fox CR; Yuan CM Nephrol Dial Transplant; 2007 Apr; 22(4):1241-6. PubMed ID: 17299002 [No Abstract] [Full Text] [Related]
32. A new machine for continuous renal replacement therapy: from development to clinical testing. Ricci Z; Salvatori G; Bonello M; Ratanarat R; Andrikos E; Dan M; Piccinni P; Ronco C Expert Rev Med Devices; 2005 Jan; 2(1):47-55. PubMed ID: 16293028 [TBL] [Abstract][Full Text] [Related]
33. End-stage renal disease in Canada: prevalence projections to 2005. Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996 [TBL] [Abstract][Full Text] [Related]
34. Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Viklicky O; Pokorna E; Vitko S; Nephrol Dial Transplant; 2006 Jul; 21(7):2025-6; author reply 2026. PubMed ID: 16735390 [No Abstract] [Full Text] [Related]
35. The role of the nephrologist in ESRD/Pre-ESRD care: a collaborative approach. Bolton WK J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S90-5. PubMed ID: 11443776 [TBL] [Abstract][Full Text] [Related]
36. Clinical experience: how much earlier should patients really start renal replacement therapy? Burkart JM J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S118-23. PubMed ID: 11443758 [TBL] [Abstract][Full Text] [Related]
37. End-stage renal failure and national resources: the Brazilian experience. Zatz R; Romão JE Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419 [TBL] [Abstract][Full Text] [Related]
38. Memoirs of a mature renal social worker. Moore RA Nephrol News Issues; 1993 Nov; 7(11):40, 42. PubMed ID: 8133917 [No Abstract] [Full Text] [Related]
39. An integrated approach to end-stage renal disease. Van Biesen W; Davies S; Lameire N Nephrol Dial Transplant; 2001; 16 Suppl 6():7-9. PubMed ID: 11568226 [No Abstract] [Full Text] [Related]
40. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Goovaerts T; Jadoul M; Goffin E Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]